Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...‘Once bitten, twice shy’ Before the pandemic, Pfizer and Sanofi had both begun to dabble in mRNA vaccines through partnerships — but Pfizer’s partner BioNTech was far further along than Sanofi’s partner...
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Putting all our eggs into a single biomedical basket works against us at a time when we need not only all tools, but all hands on deck. We must continue to take other protective steps....
...The yachts are moored in the harbour; the deck chairs are lined up at the Cinéma de la Plage. But as for this year’s film line-up, there’s one notable absence: Netflix....
...Here’s Loeb’s attack deck from back in the day. Hedge fund managers tend to have a multi-layered relationship with Sotheby’s....
...It sticks the rest of us with the tab, and it makes hardworking Americans feel like the deck is stacked against them,” he added....
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...However, in a recent note, Richard Evans, an analyst at Sector & Sovereign Research, questions the value of Pfizer “shuffling the deck” to divest its tail business, pointing out that the average age of its...
...Awkward (Financial Times) Moscow’s ‘political technologists’ specialise in creating pure spectacle (Financial Times) Sleaze v spin in Mexico’s race for reform (Financial Times) The SEC is turning into...
...- Look out for the The V Formation. - Citigroup hires a new sales trader. - US will probably experience a sovereign crisis. - Titantic, deck chairs, rearrange. - Of ink blots and green lights....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
International Edition